Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-29T00:55:30.206Z Has data issue: false hasContentIssue false
  • English
  • Français

A comparison of the influence on plasma lipids and platelet function of supplements of ω3 and ω6 polyunsaturated fatty acids

Published online by Cambridge University Press:  24 July 2007

T. A. B. Sanders  and
Michele C. Hochland
T. A. B. Sanders
Affiliation:
Department of Nutrition, Queen Elizabeth College, University of London, Campden Hill Road, London W8 7AH
Michele C. Hochland
Affiliation:
Department of Nutrition, Queen Elizabeth College, University of London, Campden Hill Road, London W8 7AH
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

1. A randomized double-blind crossover trial was carried out to compare the influence on plasma lipid concentrations, platelet thromboxane B2 production and platelet aggregation induced by ADP, collagen and U46619 (a prostaglandin endoperoxide analogue), of a daily 10 g supplement of a fish-oil concentrate (MaxEPA), which provided (g): 1·7 20:5ω3, 0·3 22:5ω3 and 1·2 22:6ω3, taken for 2 weeks by ten healthy subjects, with one of vegetable oil providing 3·4 18:2ω6.

2. A lower response to platelet aggregation induced by 0·5 μg collagen/ml but not by other aggregating agents was observed following both types of supplement. Platelet thromboxane B2 production induced by collagen also tended to be lower following the supplements.

3. Plasma total cholesterol concentrations were unaffected by the supplements. The MaxEPA but not the vegetable-oil supplement lowered the concentration of plasma triglycerides and increased that of high-density-lipoprotein-cholesterol.

Type
Research Article
Information
British Journal of Nutrition , Volume 50 , Issue 3 , November 1983 , pp. 521 - 529
Copyright
Copyright © The Nutrition Society 1983

References

Amezcua, J. L., O'Grady, J., Salmon, J. A. & Moncada, S. (1979). Thrombosis Research 16, 69–79.CrossRefGoogle Scholar
Bang, H. O. & Dyerberg, J. (1980). In Advances in Nutrition Research, vol 3., p. 1 [Draper, H. H., editor]. New York: Plenum Press.Google Scholar
Born, G. V. R. (1962). Nature 194, 927–929.CrossRefGoogle Scholar
Brox, J. H., Killie, J.-E., Gunnes, S. & Nordoy, A. (1981). Thrombosis and Haemostasis (Stuttgart) 46, 604–611.Google Scholar
Burt, R., Buss, D. H. & Kirk, R. S. (1983). Proceedings of the Nutrition Society 42, 71A.Google Scholar
Butler, K. D., Maguire, E. D., Smith, J. R., Turnbull, A. A., Wallis, R. B. & White, A. M. (1982). Thrombosis and Haemostasis (Stuttgart) 47, 46–82.Google Scholar
Doyle, W., Hare, W. R. & Crawford, M. A. (1983). Proceedings of the Nutrition Society 42, 69A.Google Scholar
Dyerberg, J., Bang, H. O., Stoffersen, E., Moncada, S. & Vane, J. R. (1978). Lancet ii, 117–119.CrossRefGoogle Scholar
Fleischman, A. I., Justice, D., Bierrenbaum, M. L., Stier, A. & Sullivan, A. (1975). Journal of Nutrition 105, 1286–1290.CrossRefGoogle Scholar
Goodnight, S. H., Harris, W. S. & Connor, W. E. (1981). Blood 58, 880–885.CrossRefGoogle Scholar
Goodnight, S. H., Harris, W. S., Connor, W. E. & Illingworth, D. R. (1982). Arteriosclerosis 2, 87–113.CrossRefGoogle Scholar
Gryglewski, R. J., Salmon, J. A., Ubatuba, F. B., Weatherley, B. C., Moncada, S. & Vane, J. R. (1979). Prostaglandins 18, 453–478.CrossRefGoogle Scholar
Hirai, A., Hamazaki, T., Terano, T., Nishikawa, T., Tamura, Y., Kumagai, A. & Sajiki, J. (1980). Lancet ii, 1132–1133.CrossRefGoogle Scholar
Hirai, A., Terano, T., Hamazaki, T., Sajiki, J., Kondo, S., Ozawa, A., Fujita, T., Miyaoto, T., Tamura, Y. & Kumagai, A. (1982). Thrombosis Research 28, 285–298.CrossRefGoogle Scholar
Hornstra, G., Lewis, B., Chait, A., Turpeinen, O., Karvonen, M. S. & Vergroesen, A. J. (1973). Lancet i, 1155–1157.CrossRefGoogle Scholar
Jakubowski, J. A. & Ardlie, N. G. (1979). Thrombosis Research 16, 205–217.CrossRefGoogle Scholar
Kobayashi, S., Hirai, A., Terano, T., Hamazak, T, Tamura, Y. & Kumagai, A. (1981). Lancet ii, 197.CrossRefGoogle Scholar
Kraemer, F. B., Greenfield, M., Tobey, T. A. & Reaven, M. (1982). British Journal of Nutrition 47, 259–288.CrossRefGoogle Scholar
Moncada, S. & Vane, J. R. (1979). New England Journal of Medicine 300, 1142–1147.CrossRefGoogle Scholar
Paul, A. A. & Southgate, D. A. T. (1978). McCance and Widdowson's The Composition of Foods, 4th ed., MRC special report no. 297. London: H.M. Stationery Office.Google Scholar
Sack, E. S. & Quiroga, E. (1976). Thrombosis and Haemostasis (Stuttgart) 35, 658.Google Scholar
Salmon, J. A. (1978). Prostaglandins 15, 382–397.Google Scholar
Sanders, T. A. B. & Roshanai, F. (1983). Clinical Science 64, 91–99.CrossRefGoogle Scholar
Sanders, T. A. B., Vickers, M. & Haines, A. P. (1981). Clinical Science 61, 317–324.CrossRefGoogle Scholar
Sanders, T. A. B. & Younger, K. M. (1981). British Journal of Nutrition 45, 613–616.CrossRefGoogle Scholar
Siess, W., Scherer, B., Bohlig, B., Roth, P., Kurzman, I. & Weber, P. C. (1980). Lancet i, 441–444.CrossRefGoogle Scholar
Sinclair, H. M. (1980). In Drugs Affecting Lipid Metabolism, pp. 363–370. [Fumagalli, R., Kritchevsky, D. & Paoletti, R., editors]. Amsterdam: Elsevier/North Holland Biomedical Press.Google Scholar
Von Lossonczy, T. O., Ruiter, A., Bronsgeest-Schoute, H. C., Van Gent, C. M. & Hermus, R. J. (1978). American Journal of Clinical Nutrition 31, 1340–1346.CrossRefGoogle Scholar